• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
  • Drug Policy and Law
  • Harm Reduction
  • Activism

Drugreporter

News and Films from the Frontline of the War on Drugs

  • News
  • Café
  • Videos
  • About Us
  • EN
    • HU
    • RU

Will Poland allow medical marijuana use?

May 30, 2013 | Author: Agnieszka Sieniawska

Tweet

Despite a growing number of countries allowing the use of marijuana for medical purposes, is the Warsaw government still on the side of prohibition? A glimmer of hope appeared recently, but will it be enough to allow those who need the plant in order to be cured?

Medical use of cannabinoids – agents found in cannabis – is increasing in a growing number of countries, including the United States, Canada, the Netherlands and lately in the Czech Republic. Poland, however, still prohibits such use. According to Polish law, marijuana is still listed as a banned substance in the Appendix to the Act on Countering Drug Addiction. Since the law does not differentiate between recreational use and medical use, possession of any quantity could imply up to 3 years' imprisonment.

At the same time cannabis is included in another Annex, which lists substances whose use is not permitted for medical purposes. As the former Health Minister Marek Balicki has said, marijuana was surely placed on that list in error, and the Polish Seym (Parliament) will need to correct that mistake. In December 2012, the Office for Registration of Medicinal Products, Medical Devices and Biotic Products reached a decision enabling trade in the medicinal product Sativex, which contains delta 9 tetrahydrocannabinol, colloquially referred to as THC. However this decision is in conflict with the prohibition on the use of marijuana for medical purposes. Up to now, it was possible to import Sativex from abroad, but only in exceptional circumstances. Moreover, it is expensive, and requires special approval from the Ministry of Health. Thus, in practice, this decision can not affect the availability of the medicine in the form of marijuana.

Thanks to the decision from the Office for Registration of Medicinal Products, Medical Devices and Biotic Products, Sativex, produced by GW Pharma Ltd in England, is the first medicine of its kind which may be bought and sold in Poland. It will be used for example in order to mitigate moderate and severe symptoms of spasticity among patients suffering from multiple sclerosis, in cases where other medicines are ineffective.

In common with other medicines containing intoxicants or psychotropic ingredients, Sativex is only available on prescription – notably the so-called ‘pink prescription’, a prescription with a duplicate. This type of prescription is used in the case of medicines which carry a risk of improper use, abuse or use for illegal purposes. Such prescriptions are required, for example, in the case of morphine-based medicines.

The effectiveness of Sativex, administered as a spray, has been confirmed by clinical research. In recent years, the preparation has been licensed in Great Britain, Spain, Germany, Denmark, Czech Republic, Sweden, New Zealand and Canada.

However, no-one knows when marijuana will be deleted from the list of substances which can not be used in medicines, and how the conflict with the Act on Countering Drug Addiction will be resolved. The Ombudsman for the Addicts' Program helps people who have been detained by the police on charges of marijuana possession for personal use and also those who have been caught in possession of marijuana for medical use. Based on the experiences of the program, law enforcement agencies do not take into account the medical purpose of possessing marijuana, so such cases often lead to a judicial sentence. In Poland, possession of any quantity of an illegal substance is punishable by up to 3 years' imprisonment – which applies equally to users of medical marijuana. The Polish Drug Policy Network prepared a draft amendment to the Polish drug law, aimed at removing marijuana from the Annex to the Act. The amendment, however, stalled in the Polish Parliament, and awaits debate, without any due date having been set.

Agnieszka Sieniawska, Chairwoman of the Polish Drug Policy Network / Polish Coordinator of the EDPI Project / Lawyer of the Ombudsman for Addicts Program

Filed Under: Articles Topics: Drug Policy and Law, European Drug Policy, Marijuana Policies, Psychedelic Medicines

Access to this article is free - but to produce articles and videos is not. Drugreporter is a non-profit website that needs your support to provide you with high quality contents.

Become a supporter and make a donation of 5 $ today!

Kapcsolódó cikkek:

The Italian Anti-Rave Law Violates Human Rights – Interview with Susanna Ronconi

February 1, 2023 - Péter Sárosi

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Kapcsolódó videók:

Decriminalisation in Portugal: Through the Lens of People who Use Drugs

December 5, 2022 - István Gábor Takács

Drugreporter News | 2022 November

November 24, 2022 - István Gábor Takács

Harm Reduction in Athens – With the Eye of an Outsider

November 23, 2022 - Péter Sárosi

You can browse our topics here:

Activism COVID-19 Criminalisation Dose of Science Drug Consumption Rooms Drug Policy and Law European Drug Policy Harm Reduction Hepatitis HIV/AIDS Marijuana Policies Medical Marijuana Needle and syringe programs New Psychoactive Substances Opiate Substitution Overdose Prevention Psychedelic Medicines Regulation and Control Russian Drug Policy Sex Work United Nations Drug Policy US Drug Policy

Primary Sidebar

BECOME A SUPPORTER OF DRUGREPORTER! INVEST THE PRICE OF A COFFEE MONTHLY AND MAKE SURE DRUGREPORTER KEEPS RUNNING!
Subscribe to the Newsletter!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
  • Facebook
  • Twitter
  • YouTube

Search

Drugreporter Video Database

Hundreds of videos on drug policy, harm reduction and human rights for streaming and download, also on a world map!

DRUGREPORTER NEWS

Monthly drug policy news from around the world

Drugreporter café

In our new online video show, we regularly discuss new developments in the world of drug policy with professionals, activists and decision makers. You can also listen to the Drugreporter Café in Podcast format on Spotify or Apple Podcasts!

COVID-19 Harm Reduction Update

On this info page Drugreporter provides regular updates about resources and news on how harm reduction service providers respond to the COVID-19 Epidemic.

Drugreporter Video Advocacy Network

Browse videos produced by members of our Drugreporter Video Advocacy Network, from all around the world!

DRUG USERS NEWS

Russian language videos on drug policy, harm reduction and human rights.

Our award winning animated documentary movie is based on the original audio recording of Kostya Proletarsky, a drug user and HIV activist who died as a result of mistreatment and torture at a Russian prison. Festival appearances, news and resources are available here!

Footer

Rights Reporter Foundation
Hungary, 1032 Budapest
San Marco Street 70.
Email: rightsreporter@rightsreporter.net

Search

Our other websites:

The Rights Reporter Foundation

The Autocracy Analyst

Room for Change Campaign

Room in the 8th District Campaign

A Day in the Life movie website

Drugreporter